Abdo Mahli
Impact in
- Pharmacology top 5%
- Hops Chemistry and Applications
- Drug-Induced Hepatotoxicity and Protection
-
- Liver physiology and pathology
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Pharmacology 12
- Hops Chemistry and Applications 6
- Drug-Induced Hepatotoxicity and Protection 5
-
- Alcohol Consumption and Health Effects 4
- Co-authors
- Claus Hellerbrand (20 shared papers)Anja‐Katrin Bosserhoff (9 shared papers)Wolfgang Erwin Thasler (10 shared papers)Martina Müller-Schilling (6 shared papers)K Freese (8 shared papers)A. Koch (4 shared papers)Ralf Weiskirchen (3 shared papers)Peter Dietrich (4 shared papers)
- Journals
- Oncotarget (4 papers)Cells (2 papers)Frontiers in Physiology (1 paper)Digestive Diseases (1 paper)Journal of Hepatology (1 paper)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Abdo Mahli
23 papers receiving 535 citations
Peers
Comparison fields: 5 of 68
- Pharmacology 133
- Hepatology 50
- Cancer Research 65
- Drug Discovery 1
- Epidemiology 107
Countries citing papers authored by Abdo Mahli
This map shows the geographic impact of Abdo Mahli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdo Mahli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdo Mahli more than expected).
Fields of papers citing papers by Abdo Mahli
This network shows the impact of papers produced by Abdo Mahli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdo Mahli. The network helps show where Abdo Mahli may publish in the future.
Co-authors
The 25 scholars most cited alongside Abdo Mahli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 80 | |
| 2 | 2017 | 54 | |
| 3 | 2016 | 53 | |
| 4 | 2015 | 48 | |
| 5 | 2015 | 45 | |
| 6 | 2016 | 45 | |
| 7 | 2019 | 41 | |
| 8 | 2017 | 30 | |
| 9 | 2021 | 28 | |
| 10 | 2015 | 27 | |
| 11 | 2018 | 25 | |
| 12 | 2019 | 23 | |
| 13 | 2018 | 22 | |
| 14 | 2018 | 4 | |
| 15 | 2024 | 4 | |
| 16 | 2016 | 3 | |
| 17 | 2018 | 3 | |
| 18 | 2023 | 3 | |
| 19 | 2015 | 2 | |
| 20 | 2016 | 2 |
About Abdo Mahli
Abdo Mahli is a scholar working on Pharmacology, Pathology and Forensic Medicine, Epidemiology, Hepatology and Oncology, having authored 24 papers that have together received 545 indexed citations. Recurring topics across this work include Hops Chemistry and Applications (6 papers), Liver Disease Diagnosis and Treatment (5 papers), Drug-Induced Hepatotoxicity and Protection (5 papers), Alcohol Consumption and Health Effects (4 papers), Cancer, Hypoxia, and Metabolism (1 paper), Antifungal resistance and susceptibility (1 paper), Structural and Chemical Analysis of Organic and Inorganic Compounds (1 paper) and COVID-19 Clinical Research Studies (1 paper). The work is most often cited by research in Pharmacology (133 citations), Hepatology (50 citations), Cancer Research (65 citations), Drug Discovery (1 citation) and Epidemiology (107 citations). Abdo Mahli has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Claus Hellerbrand, Anja‐Katrin Bosserhoff, Wolfgang Erwin Thasler, Martina Müller-Schilling, K Freese, A. Koch, Ralf Weiskirchen, Peter Dietrich, Sabine Weiskirchen and Sven Arke Lang. Their work appears in journals such as Oncotarget, Cells, Frontiers in Physiology, Digestive Diseases and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.